News for Healthier Living

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

An analysis of nationally representative survey data examined trends in glucagon-like peptide-1 receptor agonist (GLP-1RA) use and expenditure among people in the United States without diabetes.

March 31, 2025


April 9 2025

April 8 2025

April 7 2025

April 5 2025

April 4 2025

April 3 2025

April 2 2025

April 1 2025

March 31 2025

March 30 2025

March 29 2025

March 28 2025

March 27 2025

March 26 2025